Effects of Choroidal Vascular Hyperpermeability on Anti–Vascular Endothelial Growth Factor Treatment for Polypoidal Choroidal Vasculopathy
Authors:
- Han Joo ChoHCHan Joo Cho
- Hyoung Seok KimHKHyoung Seok Kim
- Young Seok JangYJYoung Seok Jang
- Jung Il HanJHJung Il Han
- Young Ju LewYLYoung Ju Lew
- Tae Gon LeeTLTae Gon Lee
- Chul Gu KimCKChul Gu Kim
- Jong Woo KimJKJong Woo Kim
- 1 December 2013
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 156 (6) , 1192-1200.e1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Relationship Between Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Choroidal Vascular HyperpermeabilityAmerican Journal of Ophthalmology, 2013
- EVEREST STUDYRetina, 2012
- One-Year Results of Three Monthly Ranibizumab Injections and As-Needed Reinjections for Polypoidal Choroidal Vasculopathy in Japanese PatientsAmerican Journal of Ophthalmology, 2012
- Choroidal Thickness, Vascular Hyperpermeability, and Complement Factor H in Age-Related Macular Degeneration and Polypoidal Choroidal VasculopathyInvestigative Ophthalmology & Visual Science, 2012
- Predictive factors of resolved retinal fluid after intravitreal ranibizumab for polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 2011
- Choroidal Thickness in Polypoidal Choroidal Vasculopathy and Exudative Age-related Macular DegenerationOphthalmology, 2011
- Subfoveal Retinal and Choroidal Thickness After Verteporfin Photodynamic Therapy for Polypoidal Choroidal VasculopathyAmerican Journal of Ophthalmology, 2011
- Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month resultsBritish Journal of Ophthalmology, 2009
- Polypoidal Choroidal Vasculopathy with Choroidal Vascular HyperpermeabilityAmerican Journal of Ophthalmology, 2006
- Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathyOphthalmology, 2004